Testing a diabetes medication for irregular heartbeat

This trial is testing whether dapagliflozin, a diabetes medication, can help reduce how often your heart experiences atrial fibrillation (an irregular heartbeat). People with both diabetes and atrial fibrillation are at higher risk for heart problems, and researchers believe this medication may have protective effects on the heart beyond helping with blood sugar control. The study will track how much time you spend in irregular rhythms and how the condition affects your quality of life.

While this medication has been shown to protect the heart in many ways, researchers have never specifically studied whether it can prevent or reduce irregular heartbeats in people who have both conditions. This trial will fill that gap and help doctors understand if this treatment could become a new option for patients like you.